Redeye considers Arise’s Q1 2025 report to be a mixed bag, although largely in line with our estimat...
Redeye provides an initial comment on the Q1 2025 report from Tradedoubler.
Redeye thinks that Momentum Group reported mixed results with both sales and EBITA slightly below ou...
Redeye comments on Formpipe’s Q1 report showing an ACV and EBITDA – CAPEX roughly matching our expec...
Sales SEK 9.5m, EBIT SEK -14m (vs. ABGSCe 9.5m and -20m) No system deliveries in the quarter, as exp...
CEO Rikard Fröberg gives a short introduction of his background and his plans for Hexatronic.
Redeye updates its view of Curasight following the Q1 report and recent events in the company, inclu...
Redeye believes Sdiptech's Q1 report was solid despite a drop in organic sales and adjusted EBITA wh...
Redeye comments on M.O.B.A. Network’s Q1 2025 report, which came in below our expectations.
Redeye comments on SHH´s Q1 2025. SSH posted a growth of 8% Y/Y slightly lower than our estimate.
Taaleri’s continuing earnings of EUR 9.3m declined 9% y/y and were 6% below our estimate.
Redeye comments on Hexatronic’s Q1 report, showing a strong development in Data Center but with Fibe...
Redeye updates its view on NextCell following an uneventful Q2 2024/2025 report and the company’s op...
Redeye updates in EG7 ahead of Q1-results (due May 15) where we expect stable performance from EG7’s...
Redeye provides its initial take on MedCap’s Q1 2025 report, which broadly aligned with our estimate...
Redeye has updated its estimates following Heliospectra’s Q1 2025 report.
Net sales and adjusted EBITDA were below our expectations in Q1, but the company reiterated its clea...
Redeye changes its Base Case and forecasts following a mixed Q1 report from Addnode.
Minor negative revisions following Q1 report Earnings growth of ~40% in '25e Trading ~20% below sect...
Cedergrenska AB (”Cedergrenska” eller ”Koncernen”) meddelade den 28 april 2025 att Koncernen förvärv...